ARS Pharmaceuticals, Inc.
← Back to SPRY Overview

ARS Pharmaceuticals, Inc. (SPRY)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-6.95

Financial Fundamentals

SPRYQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-12-31-29.65
2020-03-31-39.15
2020-06-30-33.62
2020-12-31-30.72
2021-03-31-81.63
2021-06-30-57.96
2021-09-30-15.03
2021-12-31-11.35
2022-03-31-11.35
2022-06-30-15.48
2022-09-30-18.80
2022-12-31-5.91
2023-03-31-10.25
2023-06-30-9.15
2023-09-30-6.08
2023-12-31-18.37
2024-03-31-22.20
2024-06-30-16.88
2024-09-30-18.39
2024-12-315.17
2025-03-31-9.09
2025-06-30-9.56
2025-09-30-4.85
2025-12-31-6.95

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.